InterCure Ltd.
Price Action
Technical Summary
CONSOLIDATINGInterCure Ltd. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 44), showing significant lag compared to the market leaders. Earnings contraction of 200% provides fundamental context to the price action. Investors should exercise caution due to high volatility (59% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.00 | +4.12% | ABOVE |
| 50 SMA | $0.91 | +14.35% | ABOVE |
| 100 SMA | $0.86 | +20.79% | ABOVE |
| 150 SMA | $0.95 | +8.98% | ABOVE |
| 200 SMA | $1.09 | -4.60% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is INCR in an uptrend right now?
INCR has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is INCR overbought or oversold?
INCR's RSI (14) is 56. The stock is in neutral territory, neither overbought nor oversold.
Is INCR outperforming the market?
INCR has a Relative Strength (RS) Rating of 44 out of 99. INCR is currently lagging the broader market.
Where is INCR in its 52-week range?
INCR is trading at $1.04, which is 59% of its 52-week high ($1.77) and 33% above its 52-week low ($0.68).
How volatile is INCR?
INCR has a Beta of 0.91 and 52-week volatility of 59%. It's less volatile than the S&P 500 - generally more stable.